Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Stock market chart on LCD screen. Selective focus.
December 17, 2025 12:14 AM 2 min read

What Sparked Aditxt (ADTX) Stock's 52% After‑Hours Surge?

by Mohd Haider Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

Aditxt Inc. (NASDAQ:ADTX) shares surged 52.11% in after-hours trading to $2.16 on Tuesday following the company’s filing of a definitive proxy statement for a special stockholder virtual meeting scheduled for Jan. 30, 2026.

Check out the current price of ADTX stock here.

Multiple Shareholder Proposals

The proxy statement outlines several critical proposals requiring shareholder approval.

According to the Securities and Exchange Commission filing dated Tuesday, stockholders of record as of Dec. 5 will vote on Nasdaq Marketplace Rule 5635(d) compliance, which requires shareholder approval for issuances exceeding 20% of outstanding shares at below-market prices.

The proposals cover the issuance of common stock underlying Series A-1 Convertible Preferred Stock from December 2023, Series C-1 Convertible Preferred Stock and warrants from May and August 2024, and common stock purchase warrants from July 2024.

See Also: Is Tilray Stock Headed To New Highs? What You Need To Know

Equity Incentive Expansion

Aditxt also seeks approval for the company’s 2025 Employee Stock Purchase Plan, which allows employees to purchase company stock at a discount through payroll deductions, and an amendment to the 2021 Omnibus Equity Incentive Plan, a compensation framework for granting stock options and equity awards to employees and directors, increasing the number of shares from 3 to 350,000.

The board seeks discretionary authority to effect a reverse stock split at a ratio between 1-for-5 and 1-for-250, with the exact ratio to be determined by the board, within one year of stockholder approval.

Strategic Name Change

Stockholders will additionally cast a non-binding advisory vote on changing the company name from “Aditxt, Inc.” to “bitXbio, Inc.“

Kingsdale Advisors will serve as the strategic stockholder advisor and proxy solicitation agent.

Trading Metrics

ADTX has fallen 99.97% year to date. The California-based biotech has a market capitalization of $794,410.

Price Action: According to Benzinga Pro data, Aditxt shares closed down 1.39% at $1.42 on Tuesday.

Benzinga's Edge Stock Rankings indicates ADTX stock has a negative price trend across all time frames. Here is how the stock fares on other parameters.

Read Next:

  • Vision Marine Technologies (VMAR) Stock Popped 157% on Tuesday: Here’s Why It’s Trending

Photo Courtesy: g0d4ather on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
BiotechEquitiesNewsFinancingStock SplitSECAfter-Hours CenterMarketsGeneralwhy it's moving
ADTX Logo
ADTXAditxt Inc
$0.7500-8.12%
Overview
ADTX Logo
ADTXAditxt Inc
$0.7500-8.12%
Overview
Comments
Loading...